Literature DB >> 159311

Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.

J P Halper, S M Fu, A B Gottlieb, R J Winchester, H G Kunkel.   

Abstract

The human Ia-like antigens, selectively expressed on B lymphocytes, are now recognized to be closely associated with, or identical to, the gene products of the major histocompatibility complex responsible for stimulation in the mixed lymphocyte reaction. The leukemic B lymphocytes of patients with chronic lymphocytic leukemia express these antigens very well. In the present study they were readily detected by several techniques utilizing both allo- and heteroantisera. However, the leukemic B cells from most patients were found to be extremely poor stimulating cells in the mixed lymphocyte reaction. This was particularly apparent when comparisons were made on a B-cell basis with isolated normal B lymphocytes. Leukemic cell death, abnormal kinetics of leukemic cell-mediated stimulation, and serum or cellular suppressor factors do not appear to explain these findings. Studies comparing cells from a leukemic patient with those of her HLA identical sibling and results of mixed lymphocyte reactions between normal and leukemic subjects discordant for D-region-associated Ia antigens ruled out genetic explanations for the differences observed. Experiments with normal peripheral blood mononuclear cells depleted of T cells and monocytes exclude the quantitative deficiency of monocytes which is found in the peripheral blood of most leukemic patients as an explanation. The present results with chronic lymphocytic leukemia cells indicate that the mere expression of the Ia-like antigens by cell populations does not render them effective stimulators. The accumulated evidence obtained indicate that abnormalities, particularly of membrane function and metabolism, known to occur in chronic lymphocytic leukemia lymphocytes may be involved in the poor stimulatory capacity of the leukemic B cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159311      PMCID: PMC371258          DOI: 10.1172/JCI109567

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

2.  MLC stimulatory capacity and production of blastogenic factor in patients with chronic lymphatic leukemia and Hodgkin's disease.

Authors:  S Kasakura
Journal:  Blood       Date:  1975-06       Impact factor: 22.113

3.  Stimulating capacity of human lymphoid cell subpopulations in mixed lymphocyte cultures.

Authors:  D Albrechtsen; M Lied
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  The mixed lymphocyte reaction (MLR) stimulatory capacity of human lymphocyte subpopulations.

Authors:  M H van Oers; W P Zeijlemaker
Journal:  Cell Immunol       Date:  1977-06-15       Impact factor: 4.868

5.  T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.

Authors:  T Han; B Dadey
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

6.  Presence of HLA-D determinants on human macrophages.

Authors:  H Hirschberg; A Kaakinen; E Thorsby
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

7.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

8.  Mixed lymphocyte cultures in rheumatoid arthritis.

Authors:  P Stastny
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; M D Witmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes.

Authors:  S M Fu; N Chiorazzi; H G Kunkel; J P Halper; S R Harris
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  18 in total

1.  A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.

Authors:  Davide Bagnara; Matthew S Kaufman; Carlo Calissano; Sonia Marsilio; Piers E M Patten; Rita Simone; Philip Chum; Xiao-Jie Yan; Steven L Allen; Jonathan E Kolitz; Sivasubramanian Baskar; Christoph Rader; Hakan Mellstedt; Hodjattallah Rabbani; Annette Lee; Peter K Gregersen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

2.  Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.

Authors:  A D Yurochko; P S Nagarkatti; M Nagarkatti; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 3.  Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.

Authors:  Rajendra N Damle; Carlo Calissano; Nicholas Chiorazzi
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

4.  B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.

Authors:  L Matera; R Foa; M Massaia; M Giovarelli; F Veglia; A Cesano; P Lusso; A Piazza; D Santoli
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Antigen presentation to human T lymphocytes. I. Different requirements for stimulation by hapten-modified cells vs. cell sonicates.

Authors:  S L Abramson; J M Puck; R R Rich
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

6.  Rheumatoid non-lymphoid synovial cells and the induction of mixed leukocyte reactions. Low-density preparations containing Ia+ macrophages and dendritic cells are less stimulatory than peripheral blood non-T cells.

Authors:  G R Burmester; J Schneeberger; B Jahn; M Gramatzki; J Zacher; J R Kalden
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  K Guy; R R Meehan; A E Dewar; D Larhammar
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

8.  DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells.

Authors:  F Vánky; E Klein; J Willems
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

Authors:  G M Taylor; W Fergusson; P A Dyer; R Harris; G Morrell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Expression of ICAM-1 (CD54) on normal and leukaemic B cells: implication for the mixed lymphocyte reaction.

Authors:  M R Padros; M I Noli; L Fainboim
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.